Autoimmune
|
September 24, 2024

Treatment Options for Rheumatoid Arthritis: Medications and Therapies

Written By
Medically Reviewed by
Updated On
September 30, 2024

‍Rheumatoid Arthritis (RA) is a condition that challenges the body’s balance, turning what should be simple movements into daily obstacles. But with the right approach, managing RA becomes a journey of resilience rather than a battle.Β 

Effective treatment doesn’t just alleviate symptomsβ€”it empowers individuals to regain control, preserving both their mobility and quality of life. This article offers a clear guide to the various treatments available, helping you navigate the path to living well with RA.

[signup]

Understanding the Goals of RA Treatment

Rheumatoid Arthritis(RA) is a chronic autoimmune disease that primarily targets the joints, leading to inflammation, pain, and potentially long-term joint damage. The primary objectives of RA treatment are twofold: to alleviate the symptoms that significantly impact daily life and to prevent further progression of the disease.

The primary aim is to control inflammation, which is central to reducing pain and preventing further joint damage. Medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs) are commonly used to achieve this goal.

Early treatment is essential to prevent irreversible joint damage and maintain joint function. Biologic agents and Janus kinase (JAK) inhibitors are often prescribed when conventional DMARDs are insufficient.

Personalized Treatment Plans

RA affects individuals differently, and the severity of the disease can vary widely. Therefore, treatment plans must be personalized to address each patient's specific needs. Healthcare providers consider several factors when designing a treatment plan.

The extent of joint involvement and the overall severity of RA play a significant role in determining the appropriate treatment. Over-the-counter medications and lifestyle modifications may be sufficient for mild cases, while more severe cases may require a combination of DMARDs, biologics, and corticosteroids.

The type and intensity of symptoms experienced by the patient also guide treatment decisions. For instance, patients with significant pain or fatigue may benefit from pain-relieving medications and therapies designed to boost energy levels and improve well-being.

A patient's overall health, including any comorbid conditions, shapes their treatment plan. For example, certain medications used to treat RA may not be suitable for patients with underlying health issues such as liver or kidney disease. In such cases, alternative treatments or lower doses may be considered to minimize the risk of adverse effects.

Medications for Rheumatoid Arthritis

1. Disease-Modifying Antirheumatic Drugs (DMARDs)

Methotrexate is the most commonly prescribed DMARD for RA. It works by inhibiting the metabolism of folic acid, which is essential for the synthesis of nucleic acids and the proliferation of cells, thereby reducing inflammation and slowing disease progression. Potential side effects include liver toxicity, bone marrow suppression, and gastrointestinal issues.

Other DMARDs include:

  • Leflunomide: Inhibits pyrimidine synthesis, reducing lymphocyte proliferation. It is effective as a single agent or in combination with methotrexate.
  • Sulfasalazine and Hydroxychloroquine: Typically used for mild disease, these drugs have anti-inflammatory and immunomodulatory effects.

DMARDs are most effective when started early in the course of the disease. Early intervention with DMARDs can slow the progression of RA, prevent joint damage, and improve long-term outcomes.Β 

2. Biologic Response Modifiers (Biologics)

Biologics are a newer class of RA medications that target specific aspects of the immune system.Β 

  • TNF Inhibitors (e.g., Etanercept, Infliximab): TNF inhibitors, such as etanercept and infliximab, block the action of tumor necrosis factor (TNF), a substance in the body that contributes to inflammation.Β  These medications are usually prescribed for patients who do not respond adequately to DMARDs. TNF inhibitors are administered by injection or infusion and have been shown to be highly effective in reducing symptoms and preventing joint damage.
  • IL-6 Inhibitors (e.g., Tocilizumab): Interleukin-6 (IL-6) inhibitors, such as tocilizumab, target another pathway involved in inflammation. IL-6 is a cytokine that plays a role in the immune response, and by blocking its action, IL-6 inhibitors help reduce inflammation and slow disease progression. These biologics are especially useful for patients who have not responded to other treatments.
  • Other biologics include:

Rituximab: Rituximab targets CD20 on B cells, which are used for refractory RA, especially in seropositive patients.

Abatacept: Inhibits T-cell activation, suitable for patients who do not respond to other treatments.

While biologics can be highly effective, they also carry risks. Suppressing the immune system increases the risk of infections, including serious ones like tuberculosis and opportunistic infections.

3. Janus Kinase (JAK) Inhibitors

JAK inhibitors are a newer class of oral medications that target specific enzymes involved in the immune response.Β 

Tofacitinib, baricitinib, and upadacitinib work by inhibiting Janus kinase (JAK) pathways, which play a role in the inflammatory process. These medications are particularly useful for patients who do not respond to traditional DMARDs or biologics.

JAK inhibitors offer the convenience of oral administration and have shown effectiveness in reducing RA symptoms and slowing disease progression. However, like biologics, they can increase the risk of infections, and there are concerns about their potential impact on blood clotting and cholesterol levels. Regular monitoring is necessary to manage these risks.

4. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

NSAIDs, such as ibuprofen and naproxen, are commonly used to manage the pain and inflammation associated with RA. These medications work by blocking the production of prostaglandins, chemicals that cause inflammation. While NSAIDs can provide significant relief from symptoms, they do not modify the underlying disease process or prevent joint damage.

NSAIDs are best used as a symptom management tool rather than a primary treatment for RA. Long-term use can lead to gastrointestinal issues, cardiovascular risks, and kidney problems, so they are usually prescribed at the lowest effective dose for the shortest duration necessary.

5. Corticosteroids

Corticosteroids, such as prednisone and methylprednisolone, are powerful anti-inflammatory medications that can quickly reduce inflammation and control RA symptoms. They are often used to manage acute flare-ups or as a bridge therapy until DMARDs or biologics take effect.

While corticosteroids can be highly effective in the short term, long-term use carries significant risks, including osteoporosis, weight gain, diabetes, and increased susceptibility to infections. For this reason, doctors aim to use the lowest effective dose and taper corticosteroids as soon as other treatments become effective.Β 

The goal is to minimize potential side effects while maintaining control of the disease.

Non-Pharmacological Therapies for RA

In addition to medications, non-pharmacological therapies play a crucial role in the comprehensive management of Rheumatoid Arthritis (RA).Β 

1. Physical Therapy

Physical therapy is important in managing RA because it helps maintain joint flexibility, strength, and function.

  • Exercise Programs: Tailored exercise programs are designed to improve joint flexibility, muscle strength, and overall function. Low-impact exercises such as walking, swimming, and cycling are often recommended.
  • Range of Motion Exercises: These exercises are vital for maintaining flexibility in affected joints, preventing stiffness, and improving mobility.
  • Pain Relief Techniques: Physical therapists use heat, cold, and ultrasound to manage pain and reduce inflammation, enhancing patient comfort and mobility.

2. Occupational Therapy

Occupational therapy helps RA patients perform daily activities more efficiently and with less pain.

  • Assistive Devices: Tools such as jar openers, reachers, and specialized kitchen utensils help reduce joint strain during daily tasks.
  • Ergonomic Adjustments: Modifying home and workplace environments to be more ergonomic can significantly reduce the impact of RA on daily life. This includes adjusting chair heights, using supportive cushions, and organizing workspaces to minimize joint stress.
  • Joint Protection Techniques: Patients are educated on techniques to avoid joint stress, such as using larger joints for tasks and distributing weight evenly.

3. Complementary and Alternative Therapies

Many RA patients explore complementary therapies to manage symptoms and improve well-being.

  • Acupuncture: Acupuncture practice can alleviate symptoms like joint pain and stiffness by modulating the nervous system and reducing inflammation.
  • Massage Therapy: Massage can help reduce pain, improve circulation, and promote relaxation, contributing to overall symptom relief.
  • Mind-Body Techniques: Practices such as yoga, meditation, and tai chi can help manage RA symptoms by reducing stress, improving flexibility, and enhancing mental well-being.

4. Lifestyle Modifications

Adopting certain lifestyle changes can have a positive impact on RA management.

  • Diet and Nutrition: An anti-inflammatory diet rich in omega-3 fatty acids, fruits, and vegetables can help reduce inflammation. The Mediterranean diet is particularly beneficial for RA patients.
  • Stress Management: Chronic stress can exacerbate RA symptoms. Techniques such as mindfulness, deep breathing, and relaxation exercises are effective in reducing stress levels.
  • Weight Management: Maintaining a healthy weight is crucial to reducing stress on joints, which can help alleviate pain and improve mobility.

Surgical Options for Rheumatoid Arthritis

Surgical intervention is considered a last resort for managing rheumatoid arthritis (RA) when conservative treatments fail to alleviate symptoms or halt disease progression. Surgery can significantly improve joint function, reduce pain, and enhance the quality of life for patients with severe joint damage.

Surgery is typically considered for RA patients when:

  • There is severe joint damage that significantly impacts daily activities.
  • The patient experiences a loss of joint function.
  • Pain becomes unmanageable with medications and other non-surgical treatments.

Types of RA-Related Surgeries

Several surgical options are available to address different aspects of joint damage in RA:

  • Synovectomy: This procedure involves removing the inflamed synovial membrane lining the joint. It aims to reduce pain and improve joint function. Synovectomy is often performed using minimally invasive arthroscopic techniques.
  • Joint Replacement (Arthroplasty): In cases of severe joint destruction, total joint replacement may be necessary. This involves replacing the damaged joint with a prosthetic implant, commonly performed on the hips, knees, and shoulders. Joint replacement can significantly reduce pain and restore mobility.
  • Tendon Repair: Chronic inflammation in RA can lead to tendon damage. Tendon repair surgery corrects this damage, restoring function and preventing further complications.

Recovery and Rehabilitation

Recovery from RA-related surgery is a critical phase that requires careful management. Physical therapy is essential after surgery to regain joint mobility, strength, and function. A tailored rehabilitation program helps ensure a successful recovery and minimizes complications.

Most patients experience significant improvements in pain and joint function after surgery. However, recovery times can vary depending on the type of surgery and the patient's adherence to rehabilitation protocols.

Combining Treatments: A Multidisciplinary Approach

Managing rheumatoid arthritis (RA) effectively requires a comprehensive, multidisciplinary approach that combines various treatment modalities. This approach ensures that all aspects of the disease are addressed, optimizing patient outcomes and quality of life.Β 

A multidisciplinary team is essential for providing coordinated care to RA patients. This team typically includes:

  • Rheumatologists: Specialists who oversee the overall management of RA, including diagnosis, medication prescriptions, and monitoring disease progression.
  • Physical Therapists: Professionals who develop exercise programs to maintain joint flexibility and strength and provide pain relief techniques.
  • Occupational Therapists: Experts who assist patients in performing daily activities with minimal joint strain, recommending assistive devices and ergonomic adjustments.
  • Surgeons: Orthopedic surgeons who evaluate and perform surgical interventions when necessary, such as joint replacements or tendon repairs.

Effective communication and collaboration among these healthcare providers ensure that treatment plans are comprehensive and tailored to the individual needs of the patient.

Balancing Medications and Therapies

Rheumatoid arthritis is a dynamic disease that can change over time, requiring continuous adjustments to the treatment plan. Balancing medications with physical and occupational therapies is essential to managing symptoms effectively and preventing long-term joint damage. As the disease progresses or as patients respond differently to treatment, healthcare providers may need to modify dosages, introduce new therapies, or adjust the intensity of rehabilitation exercises.

For example, a patient who initially responds well to DMARDs might later require the addition of biologics or JAK inhibitors if the disease becomes more aggressive. Similarly, non-pharmacological therapies might need to be intensified if the patient experiences a flare-up or new joint involvement. Adapting the treatment plan in response to the patient’s condition is key to managing RA effectively over the long term.

[signup]

Key Takeaways

  • Rheumatoid Arthritis (RA) is a chronic autoimmune disease that primarily affects the joints, causing inflammation, pain, and potential long-term joint damage.
  • Early and aggressive treatment with medications like DMARDs, biologics, and JAK inhibitors is crucial for controlling inflammation, reducing symptoms, and preventing irreversible joint damage.
  • Personalized treatment plans are essential, as RA affects individuals differently, and factors such as disease severity, symptoms, and overall health guide the choice of therapy.
  • Non-pharmacological therapies, including physical and occupational therapy, play a vital role in maintaining joint function, managing symptoms, and improving quality of life.
  • Surgical options, such as joint replacement and synovectomy, are considered when conservative treatments fail, offering relief and improved function for patients with severe joint damage.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Adas, M. A., Alveyn, E., Cook, E., Dey, M., Galloway, J. B., & Bechman, K. (2021). The infection risks of JAK inhibition. Expert Review of Clinical Immunology, 18(3), 253–261. https://doi.org/10.1080/1744666x.2022.2014323

Arthroplasty (Joint Replacement Surgery): Procedure and Details. (n.d.). Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/21649-arthroplasty-joint-replacement

Benjamin, O., Goyal, A., & Lappin, S. L. (2022, July 4). Disease Modifying Anti-Rheumatic Drugs (DMARD). PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK507863/

Blake, K. (2023, May 22). Anti Inflammatory Diet 101: What to Eat and Avoid Plus Specialty Labs To Monitor Results. Rupa Health. https://www.rupahealth.com/post/anti-inflammatory-diet

Bobek, D. (2022). Use of Non-Steroidal Anti-Inflammatory Drugs in Patients with Advanced Active Rheumatoid Arthritis. Acta Clinica Croatica. https://doi.org/10.20471/acc.2022.61.04.04

Bobos, P., Nazari, G., Lalone, E. A., Ferreira, L., Grewal, R., & MacDermid, J. C. (2018). A Scoping Review of Joint Protection Programs for People with Hand Arthritis. The Open Orthopaedics Journal, 12(1), 500–513. https://doi.org/10.2174/1874325001812010500

Chou, P.-C., & Chu, H.-Y. (2018). Clinical Efficacy of Acupuncture on Rheumatoid Arthritis and Associated Mechanisms: A Systemic Review. Evidence-Based Complementary and Alternative Medicine, 2018, 1–21. https://doi.org/10.1155/2018/8596918

Crawford, C., Boyd, C., Paat, C. F., Price, A., Xenakis, L., Yang, E., & Zhang, W. (2016). The Impact of Massage Therapy on Function in Pain Populationsβ€”A Systematic Review and Meta-Analysis of Randomized Controlled Trials: Part I, Patients Experiencing Pain in the General Population. Pain Medicine, 17(7), 1353–1375. https://doi.org/10.1093/pm/pnw099

Creedon, K. (2022a, March 18). 8 Ways To Prevent Osteoporosis As You Age. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-osteoporosis

Creedon, K. (2022b, May 26). How To Naturally Relieve Rheumatoid Arthritis Pain. Rupa Health. https://www.rupahealth.com/post/natural-treatments-for-rheumatoid-arthritis-pain

Crofford, L. J. (2013). Use of NSAIDs in treating patients with arthritis. Arthritis Research & Therapy, 15 Suppl 3(Suppl 3), S2. https://doi.org/10.1186/ar4174

Curtis, J. R., & Singh, J. A. (2011). Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of Care. Clinical Therapeutics, 33(6), 679–707. https://doi.org/10.1016/j.clinthera.2011.05.044

DePorto, T. (2023, January 6). Omega 3’s: The Superfood Nutrient You Need To Know About. Rupa Health. https://www.rupahealth.com/post/omega-3s-the-superfood-nutrient-you-need-to-know-about

Dey, M., Busby, A., Isaac, J., Pratt, A., Mwidimi Ndosi, Young, A., Lempp, H., & Nikiphorou, E. (2024). Personalised care packages for people with rheumatoid arthritis: a mixed-methods study. RMD Open, 10(1), e003483–e003483. https://doi.org/10.1136/rmdopen-2023-003483

Doumen, M., Pazmino, S., Bertrand, D., Westhovens, R., & Verschueren, P. (2023). Glucocorticoids in rheumatoid arthritis: Balancing benefits and harm by leveraging the therapeutic window of opportunity. Joint Bone Spine, 90(3), 105491. https://doi.org/10.1016/j.jbspin.2022.105491

Ghlichloo, I., & Gerriets, V. (2023, May 1). Nonsteroidal Anti-inflammatory Drugs (NSAIDs). PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK547742/

Harrington, R., Al Nokhatha, S. A., & Conway, R. (2020). JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data. Journal of Inflammation Research, Volume 13, 519–531. https://doi.org/10.2147/jir.s219586

Harrington, R., Harkins, P., & Conway, R. (2023). Janus Kinase Inhibitors in Rheumatoid Arthritis: An Update on the Efficacy and Safety of Tofacitinib, Baricitinib and Upadacitinib. Journal of Clinical Medicine, 12(20), 6690. https://doi.org/10.3390/jcm12206690

Hill, S., & Frey, N. (2021). Conventional Disease-Modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis. In PubMed. Canadian Agency for Drugs and Technologies in Health. https://www.ncbi.nlm.nih.gov/books/NBK584390/

Hoogeboom, T. J., Dronkers, J. J., Hulzebos, E. H. J., & van Meeteren, N. L. U. (2014). Merits of exercise therapy before and after major surgery. Current Opinion in Anaesthesiology, 27(2), 161–166. https://doi.org/10.1097/aco.0000000000000062

Kavuncu, V., & Evcik, D. (2019). Physiotherapy in Rheumatoid Arthritis. Medscape General Medicine, 6(2). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1395797/

Lopez-Olivo, M. A., Siddhanamatha, H. R., Shea, B., Tugwell, P., Wells, G. A., & Suarez-Almazor, M. E. (2014). Methotrexate for treating rheumatoid arthritis. Cochrane Database of Systematic Reviews, 6(6). https://doi.org/10.1002/14651858.cd000957.pub2

Martin, G. (2024). Synovectomy for inflammatory arthritis of the knee. Www.uptodate.com. https://www.uptodate.com/contents/synovectomy-for-inflammatory-arthritis-of-the-knee#:~:text=Synovectomy%20refers%20to%20the%20destruction

Mehrparvar, A. H., Heydari, M., Mirmohammadi, S. J., Mostaghaci, M., Davari, M. H., & Taheri, M. (2014). Ergonomic intervention, workplace exercises and musculoskeletal complaints: a comparative study. Medical Journal of the Islamic Republic of Iran, 28, 69. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219902/

Mohapatra, A., Patwari, S., Pansari, M., & Padhan, S. (2023). Navigating Pain in Rheumatology: A Physiotherapy-Centric Review on Non-pharmacological Pain Management Strategies. Cureus. https://doi.org/10.7759/cureus.51416

Mok, C. C. (2013). Rituximab for the Treatment of Rheumatoid arthritis: an Update. Drug Design, Development and Therapy, 8, 87. https://doi.org/10.2147/dddt.s41645

Mudano, A. S., Tugwell, P., Wells, G. A., & Singh, J. A. (2019). Tai Chi for rheumatoid arthritis. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd004849.pub2

Norelli, S. K., Long, A., & Krepps, J. M. (2023). Relaxation Techniques. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK513238/

Quartuccio, L., Zabotti, A., Del Zotto, S., Zanier, L., De Vita, S., & Valent, F. (2019). Risk of serious infection among patients receiving biologics for chronic inflammatory diseases: Usefulness of administrative data. Journal of Advanced Research, 15, 87–93. https://doi.org/10.1016/j.jare.2018.09.003

Radu, A. F., & Bungau, S. G. (2021). Management of Rheumatoid Arthritis: an Overview. Cells, 10(11), 2857. https://doi.org/10.3390/cells10112857

Range-of-motion exercises for arthritis. (2021, March 10). Harvard Health. https://www.health.harvard.edu/healthbeat/range-of-motion-exercises-for-arthritis

Schindele, S. F., Herren, D. B., & Simmen, B. R. (2011). Tendon Reconstruction for the Rheumatoid Hand. Hand Clinics, 27(1), 105–113. https://doi.org/10.1016/j.hcl.2010.10.004

Simmen, B. R., Bogoch, E. R., & Goldhahn, J. (2008). Surgery Insight: orthopedic treatment options in rheumatoid arthritis. Nature Clinical Practice Rheumatology, 4(5), 266–273. https://doi.org/10.1038/ncprheum0767

Tingle, R. (2022, June 6). 10 Type 2 Diabetes Risk Factors You May Not Know About. Rupa Health. https://www.rupahealth.com/post/what-causes-type-2-diabetes

Tuntland, H., Kjeken, I., Nordheim, L. V., Falzon, L., Jamtvedt, G., & Hagen, K. B. (2009). Assistive technology for rheumatoid arthritis. The Cochrane Database of Systematic Reviews, 2009(4). https://doi.org/10.1002/14651858.CD006729.pub2

Uhlig, T. (2012). Tai Chi and yoga as complementary therapies in rheumatologic conditions. Best Practice & Research Clinical Rheumatology, 26(3), 387–398. https://doi.org/10.1016/j.berh.2012.05.006

Uhlig, T., Bjørneboe, O., Krøll, F., Palm, Ø., Olsen, I. C., & Grotle, M. (2016). Involvement of the multidisciplinary team and outcomes in inpatient rehabilitation among patients with inflammatory rheumatic disease. BMC Musculoskeletal Disorders, 17, 18. https://doi.org/10.1186/s12891-016-0870-9

Vincent, H. K., Heywood, K., Connelly, J., & Hurley, R. W. (2012). Obesity and Weight Loss in the Treatment and Prevention of Osteoarthritis. PM&R, 4(5), S59–S67. https://doi.org/10.1016/j.pmrj.2012.01.005

Weinberg, J. (2022, November 16). 4 Science Backed Health Benefits of The Mediterranean Diet. Rupa Health. https://www.rupahealth.com/post/4-science-backed-health-benefits-of-the-mediterranean-diet

Weinberg, J. (2023, July 27). Integrative Approaches to the Testing and Treatment of Rheumatoid Arthritis: A Comprehensive Review. Rupa Health. https://www.rupahealth.com/post/integrative-approaches-to-the-testing-and-treatment-of-rheumatoid-arthritis-a-comprehensive-review

Yasir, M., & Sonthalia, S. (2023, July 3). Corticosteroid Adverse Effects. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK531462/

Yip, R. M. L., & Yim, C. W. (2019). Role of Interleukin 6 Inhibitors in the Management of Rheumatoid Arthritis. JCR: Journal of Clinical Rheumatology, Publish Ahead of Print. https://doi.org/10.1097/rhu.0000000000001293

Zamri, F., & de Vries, T. J. (2020). Use of TNF Inhibitors in Rheumatoid Arthritis and Implications for the Periodontal Status: For the Benefit of Both? Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.591365

ZoltΓ‘n Szekanecz, Buch, M. H., Charles-Schoeman, C., Galloway, J., Karpouzas, G. A., Lars Erik Kristensen, Ytterberg, S. R., Hamar, A., & Fleischmann, R. (2024). Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature Reviews Rheumatology, 20(2), 101–115. https://doi.org/10.1038/s41584-023-01062-9

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless β€” and best of all, it's free for practitioners.

Latest Articles

View more on Autoimmune
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! πŸ‘‹ Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.

Hey practitioners! πŸ‘‹ Join Dr. Terry Wahls for a 3-week bootcamp on integrating functional medicine into conventional practice, focusing on complex cases like Multiple Sclerosis. Learn to analyze labs through a functional lens, perform nutrition-focused physical exams, and develop personalized care strategies. Register Here.